Clinical observation on 167 cases with recurrent bacterial vaginosis treated with quadruple progression therapy

Objective:To observe the clinical efficacy of quadruple progression therapy in treatment of recurrent bacterial vaginosis.Methods:383 patients(excluding pregnant women and the patients at lactation period) diagnosed as recurrent bacterial vaginosis in the hospital were divided into two groups randomly,the patients in study group were treated with quadruple progression therapy,and the patients in control group were treated with conventional drug therapy;the clinical efficacies,courses of treatment,adjustion of vaginal flora,adverse reactions and recurrence rates in the two groups were observed.Results:The effective rates in treatment group and control group were 98.20% and 82.87%,respectively;the average treatment times of treatment group and control group were 5.7 days and 16.8 days,respectively,the course of treatment in treatment group was significantly shorter than that in control group;lactobacillin tablets were used in treatment group,the therapy increased the amount of lactobacillin and improved the vaginal internal environment;after follow-up for 1~3 years,the recurrence rates of treatment group and control group were 7.18% and 65.74%,respectively,the recurrence rate of treatment group was significantly lower than that of control group.Conclusion:The clinical efficacy of quadruple progression therapy is good in treatment of recurrent bacterial vaginosis,the course of treatment is short,the therapy is simple with low recurrence rate,and it can maintain microflora balance.